336 related articles for article (PubMed ID: 15034014)
1. Intralesional injection of adenovirus encoding CC chemokine ligand 16 inhibits mammary tumor growth and prevents metastatic-induced death after surgical removal of the treated primary tumor.
Guiducci C; Di Carlo E; Parenza M; Hitt M; Giovarelli M; Musiani P; Colombo MP
J Immunol; 2004 Apr; 172(7):4026-36. PubMed ID: 15034014
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy.
Narvaiza I; Mazzolini G; Barajas M; Duarte M; Zaratiegui M; Qian C; Melero I; Prieto J
J Immunol; 2000 Mar; 164(6):3112-22. PubMed ID: 10706701
[TBL] [Abstract][Full Text] [Related]
3. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity.
Guo J; Wang B; Zhang M; Chen T; Yu Y; Regulier E; Homann HE; Qin Z; Ju DW; Cao X
Gene Ther; 2002 Jun; 9(12):793-803. PubMed ID: 12040461
[TBL] [Abstract][Full Text] [Related]
4. IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2.
Jackaman C; Bundell CS; Kinnear BF; Smith AM; Filion P; van Hagen D; Robinson BW; Nelson DJ
J Immunol; 2003 Nov; 171(10):5051-63. PubMed ID: 14607902
[TBL] [Abstract][Full Text] [Related]
5. Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo.
Sharma S; Stolina M; Luo J; Strieter RM; Burdick M; Zhu LX; Batra RK; Dubinett SM
J Immunol; 2000 May; 164(9):4558-63. PubMed ID: 10779757
[TBL] [Abstract][Full Text] [Related]
6. Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases.
Yu P; Lee Y; Wang Y; Liu X; Auh S; Gajewski TF; Schreiber H; You Z; Kaynor C; Wang X; Fu YX
J Immunol; 2007 Aug; 179(3):1960-8. PubMed ID: 17641063
[TBL] [Abstract][Full Text] [Related]
7. EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-gamma-dependent antitumor responses in a lung cancer model.
Hillinger S; Yang SC; Zhu L; Huang M; Duckett R; Atianzar K; Batra RK; Strieter RM; Dubinett SM; Sharma S
J Immunol; 2003 Dec; 171(12):6457-65. PubMed ID: 14662845
[TBL] [Abstract][Full Text] [Related]
8. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
9. Helper-independent, L-selectinlow CD8+ T cells with broad anti-tumor efficacy are naturally sensitized during tumor progression.
Peng L; Kjaergaard J; Plautz GE; Weng DE; Shu S; Cohen PA
J Immunol; 2000 Nov; 165(10):5738-49. PubMed ID: 11067932
[TBL] [Abstract][Full Text] [Related]
10. Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes.
Giovarelli M; Cappello P; Forni G; Salcedo T; Moore PA; LeFleur DW; Nardelli B; Di Carlo E; Lollini PL; Ruben S; Ullrich S; Garotta G; Musiani P
J Immunol; 2000 Mar; 164(6):3200-6. PubMed ID: 10706711
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral CC chemokine ligand 5 overexpression delays tumor growth and increases tumor cell infiltration.
Lavergne E; Combadière C; Iga M; Boissonnas A; Bonduelle O; Maho M; Debré P; Combadiere B
J Immunol; 2004 Sep; 173(6):3755-62. PubMed ID: 15356122
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
[TBL] [Abstract][Full Text] [Related]
13. IL-21 induces tumor rejection by specific CTL and IFN-gamma-dependent CXC chemokines in syngeneic mice.
Di Carlo E; Comes A; Orengo AM; Rosso O; Meazza R; Musiani P; Colombo MP; Ferrini S
J Immunol; 2004 Feb; 172(3):1540-7. PubMed ID: 14734732
[TBL] [Abstract][Full Text] [Related]
14. Broadening of epitope recognition during immune rejection of ErbB-2-positive tumor prevents growth of ErbB-2-negative tumor.
Pilon SA; Kelly C; Wei WZ
J Immunol; 2003 Feb; 170(3):1202-8. PubMed ID: 12538677
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral expression of macrophage-derived chemokine induces CD4+ T cell-independent antitumor immunity in mice.
Lee JM; Merritt RE; Mahtabifard A; Yamada R; Kikuchi T; Crystal RG; Korst RJ
J Immunother; 2003; 26(2):117-29. PubMed ID: 12616103
[TBL] [Abstract][Full Text] [Related]
16. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
Aruga E; Aruga A; Arca MJ; Lee WM; Yang NS; Smith JW; Chang AE
Cancer Gene Ther; 1997; 4(3):157-66. PubMed ID: 9171934
[TBL] [Abstract][Full Text] [Related]
17. Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection.
Guiducci C; Vicari AP; Sangaletti S; Trinchieri G; Colombo MP
Cancer Res; 2005 Apr; 65(8):3437-46. PubMed ID: 15833879
[TBL] [Abstract][Full Text] [Related]
18. Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells.
Kikuchi T; Miyazawa N; Moore MA; Crystal RG
Cancer Res; 2000 Nov; 60(22):6391-5. PubMed ID: 11103803
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs.
Nakamura M; Iwahashi M; Nakamori M; Ueda K; Ojima T; Naka T; Ishida K; Yamaue H
Oncology; 2005; 68(2-3):163-70. PubMed ID: 16006753
[TBL] [Abstract][Full Text] [Related]
20. In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity.
Sun Y; Peng D; Lecanda J; Schmitz V; Barajas M; Qian C; Prieto J
Gene Ther; 2000 Sep; 7(17):1467-76. PubMed ID: 11001366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
